(SACH) Sachem Capital - Ratings and Ratios

Sachem Capital Corp. (NYSE MKT:SACH) is a real estate finance company specializing in short-term, first-lien mortgage loans for residential and commercial properties. The company focuses on serving real estate investors and developers, providing financing for acquisition, renovation, rehabilitation, development, and improvement projects. Sachem Capital Corp. operates as a real estate investment trust (REIT), enabling it to distribute a significant portion of its net income to shareholders while avoiding corporate income tax. Founded in 2010 and headquartered in Branford, Connecticut, the company has established itself as a lender in the real estate finance sector, with a portfolio centered on secured, short-duration loans.

As of the latest data, Sachem Capital Corp. has a market capitalization of $52.60M and trades on the NYSE MKT under the ticker symbol SACH. The stocks price trends reflect volatility, with a 20-day average volume of 341,877 shares and a last price of $1.05. The stock is currently trading below its 50-day and 200-day simple moving averages (SMA), which stand at $1.16 and $2.02, respectively. The average true range (ATR) of 0.06 indicates relatively low price fluctuation in recent trading sessions. The companys forward P/E ratio of 4.23 suggests expectations of future earnings growth, though the current P/E ratio is 0.00, likely due to net losses. The price-to-book (P/B) ratio of 0.24 points to a potential undervaluation relative to book value, while the price-to-sales (P/S) ratio of 4.80 reflects a moderate valuation based on revenue. However, the return on equity (RoE) of -2.06% highlights challenges in generating profits from shareholders equity.

Based on the provided and , Sachem Capital Corp. (SACH) is expected to face continued downward pressure over the next three months. The stocks recent price of $1.05 is below its 50-day and 200-day SMAs, suggesting bearish momentum. The low ATR of 0.06 indicates limited volatility, but the proximity of the current price to the SMA 20 ($1.06) could trigger a potential test of resistance levels. On the downside, a breach of the SMA 20 may lead to further declines. From a perspective, the companys negative RoE and high P/S ratio raise concerns about profitability and valuation. While the forward P/E of 4.23 suggests optimism about future earnings, the current financial metrics indicate ongoing challenges. Investors should monitor the companys ability to improve its return on equity and reduce its price-to-sales ratio to support a potential recovery.